[TA90--new neoplastic marker].
TA90 is a glycoprotein, occurring on the cell surface of many types of cancer. Determination of its concentration in human serum appears to be a good screening test in the direction of many cancers, and also can act as a monitoring index of disease, particularly in respect of melanoma. Further clinical studies are necessary in order to obtain accurate data on the TA90, and after that its determination might be made to everyday clinical practice in oncology.
Rudzki
Sławomir
S
Uniwersytet Medyczny w Lublinie, I Katedra i Klinika Chirurgii Ogólnej, Transplantacyjnej i Leczenia Zywieniowego.
Gołyski
Jakub
J
Bronikowski
Paweł
P
Gołyska
Dorota
D
D000951:Antigens, Neoplasm / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D003110:Colonic Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D012878:Skin Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000628:therapy
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; C113885:TA90 immune complex